We are live on ! Find out more
JSP

Jackson Square Partners Portfolio holdings

AUM $247M
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
-2.97%
1 Year Est. Return
+20.29%
3 Year Est. Return
+101.87%
5 Year Est. Return
+75.18%
10 Year Est. Return
+392.81%
AUM
$2.99B
AUM Growth
-$435M
Cap. Flow
+$945M
Cap. Flow %
31.56%
Top 10 Hldgs %
43.28%
Holding
86
New
1
Increased
6
Reduced
60
Closed
1

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$1.25B
2
MASI
Masimo
MASI
+$85.6M
3
MKTX icon
MarketAxess Holdings
MKTX
+$38.4M
4
STAA icon
STAAR Surgical
STAA
+$33.4M
5
HAPN
Happen Inc
HAPN
+$37.7K

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$66.2M
2
PZZA icon
Papa John's
PZZA
+$55.6M
3
NYT icon
New York Times
NYT
+$46.5M
4
LSCC icon
Lattice Semiconductor
LSCC
+$34.2M
5
ESTC icon
Elastic
ESTC
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Industrials 22.77%
3 Healthcare 17.06%
4 Financials 11.38%
5 Communication Services 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKE icon
51
Nike
NKE
$61.9B
$6.79M 0.23%
71,034
-1,187
-2% -$122K
PRFT
52
DELISTED
Perficient Inc
PRFT
$6.63M 0.22%
114,532
-33,537
-23% -$2.3M
CPRT icon
53
Copart
CPRT
$25.9B
$6.57M 0.22%
152,524
-2,344
-2% -$104K
KKR icon
54
KKR & Co
KKR
$89.2B
$6.14M 0.21%
99,727
-29,584
-23% -$1.8M
IQV icon
55
IQVIA
IQV
$34.7B
$5.74M 0.19%
29,182
-442
-1% -$96K
ABCM
56
DELISTED
Abcam PLC
ABCM
$5.48M 0.18%
242,234
– –
SGHT icon
57
Sight Sciences
SGHT
$267M
$4.9M 0.16%
1,455,009
-261,195
-15% -$1.72M
CWST icon
58
Casella Waste Systems
CWST
$5.69B
$4.61M 0.15%
60,458
– –
RMBS icon
59
Rambus
RMBS
$10.4B
$4.39M 0.15%
78,606
– –
DDOG icon
60
Datadog
DDOG
$87.9B
$4.32M 0.14%
47,391
-735
-2% -$72.7K
STVN icon
61
Stevanato
STVN
$5.37B
$3.74M 0.13%
125,901
-49,334
-28% -$1.54M
UNH icon
62
UnitedHealth
UNH
$382B
$360K 0.01%
715
-263
-27% -$129K
TMO icon
63
Thermo Fisher Scientific
TMO
$211B
$263K 0.01%
520
+53
+11% +$28.2K
ICLR icon
64
Icon
ICLR
$12.8B
$224K 0.01%
910
– –
UTHR icon
65
United Therapeutics
UTHR
$26.3B
$213K 0.01%
945
+140
+17% +$32.2K
ELV icon
66
Elevance Health
ELV
$81.9B
$165K 0.01%
380
– –
HUM icon
67
Humana
HUM
$46.7B
$151K 0.01%
310
-176
-36% -$82.7K
AON icon
68
Aon
AON
$77.3B
$81.7K ﹤0.01%
252
– –
MELI icon
69
Mercado Libre
MELI
$91.3B
$71K ﹤0.01%
56
– –
TSM icon
70
TSMC
TSM
$2.09T
$62.4K ﹤0.01%
718
– –
LULU icon
71
lululemon athletica
LULU
$13B
$45.9K ﹤0.01%
119
– –
PZZA icon
72
Papa John's
PZZA
$999M
– –
-753,177
Closed -$55.6M
1 2
3

Similar funds

OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
SRC
Stone Run Capital New York $254M AUM 12.86% 1-Year Est. Return
TCB
Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return
MTWM
Masso Torrence Wealth Management Marlton, New Jersey $240M AUM 26.41% 1-Year Est. Return
SSW
Smith Shellnut Wilson Ridgeland, Mississippi $260M AUM 19.19% 1-Year Est. Return
WS
Wela Strategies Atlanta, Georgia $264M AUM 16.32% 1-Year Est. Return
FC
Franchise Capital Grand Cayman, Cayman Islands $230M AUM 49.93% 1-Year Est. Return
KSWA
Kathleen S. Wright Associates Pittsburgh, Pennsylvania $270M AUM 12.59% 1-Year Est. Return

Jackson Square Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Jackson Square Partners held 86 positions worth $2.99B, down 13% from $3.43B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Jackson Square Partners deployed $945M of net new capital in Q3 2023, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Synopsys: 2,793,078 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Charles River Laboratories, an estimated $66.2M trimmed.

  • Jackson Square Partners's largest Q3 2023 buy was Synopsys: 2,793,078 shares worth $49.4M.
  • Jackson Square Partners added most to Masimo in Q3 2023, an estimated $85.6M increase.
  • Jackson Square Partners's biggest Q3 2023 reduction was Charles River Laboratories, cutting an estimated $66.2M.
  • Jackson Square Partners fully exited Papa John's in Q3 2023, selling an estimated $55.6M.
  • Jackson Square Partners's ten largest holdings make up 43% of its $2.99B portfolio in Q3 2023.
  • Jackson Square Partners opened 1 new position and closed 1 in Q3 2023.
  • Jackson Square Partners's portfolio value fell 13% quarter-over-quarter to $2.99B.

Based on Jackson Square Partners's 13F filing for Q3 2023, filed 13 Nov 2023.